Amendment No. 8 to Employment Agreement between the Company and Patrick J. McEnany, dated September 8, 2022
Exhibit 10.1
EXECUTION VERSION
EIGHTH AMENDMENT TO
EMPLOYMENT AGREEMENT
This EIGHTH AMENDMENT TO EMPLOYMENT AGREEMENT (Amendment) is entered into as of this 8th day of September, 2022, by and between CATALYST PHARMACEUTICALS, INC., a Delaware corporation (Company) and PATRICK J. MCENANY (Employee).
Preliminary Statements
A. | The parties have previously entered into that certain Employment Agreement, dated as of November 8, 2006 (the Original Agreement), as previously amended by that certain First Amendment to Employment Agreement, dated as of December 19, 2008 (the First Amendment), that certain Second Amendment to Employment Agreement, dated as of November 8, 2009 (the Second Amendment), that certain Third Amendment to Employment Agreement, dated as of September 14, 2011 (the Third Amendment), that certain Fourth Amendment to Employment Agreement, dated as of August 28, 2013 (the Fourth Amendment), that certain Fifth Amendment to Employment Agreement, dated as of June 23, 2016 (the Fifth Amendment), that certain Sixth Amendment to Employment Agreement, dated as of May 25, 2018 (the Sixth Amendment), and that certain Seventh Amendment to Employment Agreement, dated as of September 9, 2020 (the Seventh Amendment, and together with the Original Agreement, the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment, and the Sixth Amendment, the Employment Agreement.) Unless otherwise defined, capitalized terms used herein shall have the meanings given to them in the Employment Agreement. |
B. | The parties wish to further amend the Employment Agreement to reflect the terms set forth below. |
Agreement
NOW, THEREFORE, in consideration of the premises, the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
1. | Extension of Agreement. The outside date of the Term of the Employment Agreement is extended for a two year period from the sixteenth anniversary of the Effective Date (November 8, 2022) until the eighteenth anniversary of the Effective Date (November 8, 2024). All references in the Employment Agreement to the third anniversary of the Effective Date, the fifth anniversary of the Effective Date, the seventh anniversary of the Effective Date, the tenth anniversary of the Effective Date, the twelfth anniversary of the Effective Date, the fourteenth anniversary of the effective date, or the sixteenth anniversary of the Effective Date shall be deemed by this Amendment to now refer to the eighteenth anniversary of the Effective Date. |
1
EXECUTION VERSION
2. | Employment Agreement Remains in Effect. Except as otherwise specifically amended herein, the terms and provisions of the Employment Agreement remain in full force and effect. |
3. | Counterparts. This Amendment may be executed in counterparts. |
IN WITNESS WHEREOF, the parties have executed this Amendment, effective as of the date set forth above.
CATALYST PHARMACEUTICALS, INC. | ||
By: | /s/ Alicia Grande | |
Alicia Grande | ||
Vice President, Treasurer and CFO | ||
EMPLOYEE: | ||
/s/ Patrick J. McEnany | ||
Patrick J. McEnany |
2